QUANTUM X LABS INC. quarterly report, Q3 FY2012

Business context and reporting period

The supplied filing is Zaxis International Inc.’s unaudited Form 10-Q for the quarter and nine months ended September 30, 2012; it does not identify Quantum X Labs Inc. as the registrant. Zaxis reports no current business operations and describes itself as a shell company seeking a business combination. It had not identified a target business.

Financial results and liquidity

MetricThree months ended Sep. 30, 2012Nine months ended Sep. 30, 2012Prior-year comparable
Revenue$0$0$0
General and administrative expense$9,500$30,500$9,500; $30,930
Interest expense$2,550$7,650$1,750; $3,850
Net loss$(12,050)$(38,150)$(11,250); $(34,780)
Net loss per share$(0.01)$(0.02)$(0.01); $(0.02)

At September 30, 2012, cash and total assets were $0. Current liabilities totaled $214,829, versus $176,679 at December 31, 2011; shareholders’ deficit was $214,829. Liabilities included $85,000 in convertible notes, $19,300 accrued interest, $110,029 due to related parties, and $500 accounts payable. The notes bear 12% annual interest, mature December 31, 2012, and are convertible at $0.10 and $0.03 per share, respectively.

For the first nine months, operating, investing, and financing cash flows and the change in cash were each reported as $0. The operating cash flow reconciliation included $27,000 of noncash related-party services and an $11,150 increase in accounts payable and accrued liabilities. With no revenue or assets, conventional operating margins are not meaningful.

Changes, outlook, and risks

Nine-month net loss increased to $38,150 from $34,780, principally reflecting higher interest expense; general and administrative expense was slightly lower. Management says it will use limited resources to seek a business combination and may seek debt or equity financing, but has no financing agreements and gives no transaction timetable or financial guidance. Management warns that financing may not be available on acceptable terms, and that issuing shares could dilute existing holders or change control. It also cites substantial doubt about the company’s ability to continue as a going concern; the financial statements include no adjustments for this uncertainty.

Other disclosed risks include dependence on a single potential business combination, inability to assess an unidentified target’s merits in advance, and risks associated with acquiring an early-stage or financially unstable business. Management states its chief executive and financial officer concluded disclosure controls were effective at period-end and reported no material quarterly change in internal control over financial reporting. No legal proceedings were reported.

Important facts for investors to verify

  • Confirm the intended issuer: the provided filing names Zaxis International Inc., not Quantum X Labs Inc.
  • Verify the status, maturity, accrued interest, and conversion terms of the $85,000 related-party notes.
  • Review the $110,029 related-party balance, including advances and accrued services, and the statement that management owns 82% of outstanding shares.
  • Assess the company’s ability to fund ongoing costs and complete a business combination despite zero cash and substantial going-concern doubt.
  • Check subsequent filings for any business-combination target, financing, share issuance, or change in control.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.